DR info

Clinical trials : 10 / Drugs : 7 - (DrugBank : 1) / Drug target genes : 16 - Drug target pathways : 7

PCDH19 related syndrome and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability

ID	Diseases (Sorted by drug repositionability)
152	PCDH19 related syndrome
36	Epidermolysis bullosa
144	Lennox-Gastaut syndrome
13	Multiple sclerosis/Neuromyelitis optica
193	Prader-Willi syndrome
6	Parkinson disease
21	Mitochondrial disease
2	Amyotrophic lateral sclerosis
75	Cushing disease
231	Alpha-1-antitrypsin deficiency
17	Multiple system atrophy
34	Neurofibromatosis
46	Malignant rheumatoid arthritis
84	Sarcoidosis
96	Crohn disease
98	Eosinophilic gastrointestinal disease
158	Tuberous sclerosis
8	Huntington disease
5	Progressive supranuclear palsy
156	Rett syndrome
272	Fibrodysplasia ossificans progressiva
298	Hereditary pancreatitis
97	Ulcerative colitis
206	Fragile X syndrome
296	Biliary atresia
22	Moyamoya disease
70	Spinal stenosis
140	Dorabe syndrome
3	Spinal muscular atrophy
145	West syndrome
201	Angelman syndrome
18	Spinocerebellar degeneration
205	Fragile X syndrome related disease
155	Acquired aphasia with convulsive disorder